#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5968	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2421	681.6	0	.	n	.	0	A69G	SNP	69	69	A	516	516	G	790	G,A,T,C	477,167,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5968	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2421	681.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1897	1897	T	912	T,G	758,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5968	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2421	681.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1631	1631	C	804	C,A	629,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5968	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2421	681.6	0	HET	.	.	.	C751T,A	.	751	751	C	1198	1198	C	853	C,T,A	310,354,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10632	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4100	718.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1902	1902	A	852	A	673	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10632	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4100	718.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2536	2536	C	837	C,A	674,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10632	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4100	718.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2610	2610	A	890	A,C	717,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	10632	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4100	718.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3162	3162	C	806	C,G,A	632,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	862	folP	852	852	99.88	folP.l15.c4.ctg.1	2025	119.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1007	1009	AAA	166;166;165	A,C;A;A,C	134,1;137;133,2	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	862	folP	852	852	99.88	folP.l15.c4.ctg.1	2025	119.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1238	1240	AGC	150;150;149	A,C;G,T;C	115,1;118,2;117	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2084	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3724	155.1	1	SNP	p	S91F	0	.	.	271	273	TCC	731	733	TCC	156;157;158	T;C;C	127;128;128	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2084	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3724	155.1	1	SNP	p	D95G	0	.	.	283	285	GAC	743	745	GAC	157;156;156	G;A,G;C	121;119,1;120	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2084	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3724	155.1	1	SNP	p	D95N	0	.	.	283	285	GAC	743	745	GAC	157;156;156	G;A,G;C	121;119,1;120	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	888	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1617	155.0	1	SNP	p	G45D	0	.	.	133	135	GGC	618	620	GGC	223;222;220	G;G;C	183;185;179	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	550	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1320	117.5	0	.	n	.	0	A197.	DEL	197	197	A	765	765	A	222	A	183	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	283	1884	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3838	137.3	1	SNP	p	D86N	0	.	.	256	258	GAC	903	905	GAC	172;175;175	G,A;A,C;C	131,1;127,2;130	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	283	1884	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3838	137.3	1	SNP	p	S87W	0	.	.	259	261	AGT	906	908	AGT	172;173;174	A;G;T,G	127;129;128,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	283	1884	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3838	137.3	1	SNP	p	S87R	0	.	.	259	261	AGT	906	908	AGT	172;173;174	A;G;T,G	127;129;128,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	283	1884	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3838	137.3	1	SNP	p	S87I	0	.	.	259	261	AGT	906	908	AGT	172;173;174	A;G;T,G	127;129;128,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	283	1884	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3838	137.3	1	SNP	p	S88P	0	.	.	262	264	TCC	909	911	TCC	175;173;173	T;C;C	134;131;133	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1694	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3158	148.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1793	1795	GGC	191;190;192	G,A;G;C	148,1;150;151	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1361	1363	GCA	214;216;216	G,A;C;A,C	174,1;165;172,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1364	1366	ATC	215;215;216	A;T;C,A	174;165;165,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1376	1378	GTG	227;226;227	G,T;T,G;G	177,2;168,1;170	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1376	1378	GTG	227;226;227	G,T;T,G;G	177,2;168,1;170	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1880	1882	ACC	183;184;185	A,C;C;C	146,2;154;153	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1934	1936	GCG	178;178;179	G;C;G	146;143;143	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1934	1936	GCG	178;178;179	G;C;G	146;143;143	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2057	2059	GGC	192;193;190	G,C;G;C	151,1;154;152	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2066	2068	GGC	187;189;190	G,C;G;C	148,1;149;153	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1678	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2584	178.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2084	2086	CTG	190;190;189	C,G;T;G,C	153,2;150;150,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2290	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3482	182.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1819	1821	CCG	156;156;155	C,G;C;G	116,1;115;115	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	920	porA	1146	1146	99.65	porA.l6.c17.ctg.1	2112	121.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	723	723	C	130	C	108	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	582	584	GAA	267;267;268	G,C;A;A	203,1;210;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	870	872	GAT	270;272;272	G;A,C;T	199;203,1;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	993	995	TCA	263;265;264	T,C;C;A	195,1;206;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1122	1124	GTC	264;264;262	G,A,T;T;C	203,1,1;214;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1452	1454	GCA	235;234;233	G,T;C,A;A,G	194,1;191,1;193,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	1	SNP	p	G120K	1	.	.	358	360	AAG	828	830	AAG	282;282;281	A,G;A;G,T	207,2;218;214,2	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	1	SNP	p	D121N	0	.	.	361	363	GAC	831	833	GAC	279;280;280	G;A;C,A	217;216;206,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1352	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2088	179.9	1	SNP	p	A121D	1	.	.	361	363	GAC	831	833	GAC	279;280;280	G;A;C,A	217;216;206,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	4384	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5227	232.7	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2138	2140	AAT	222;222;222	A;A;T,C,A	170;176;174,1,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	634	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1473	123.1	1	SNP	p	V57M	1	.	.	169	171	ATG	726	728	ATG	250;250;250	A;T;G	199;200;197	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
